News and Media

List of News

The SUMIT trial demonstrates feasibility of the rapid conduct of pivotal clinical trials in Uveal Melanoma

In patients with metastatic uveal melanoma, the combination of selumetinib plus dacarbazine had a tolerable safety profile but did not significantly improve PFS compared with placebo plus dacarbazine. Despite the results of this study, additional assessment of MEK inhibitors in uveal melanoma is warranted.

2017 ASCO Annual Meeting - Interview to Sophie Piperno-Neumann

The 2017 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago, Illinois, 2nd-6th June 2017.

Second Meeting of the UM Cure 2020 Scientific Advisory Board

Having taken place on 18th January at the Institut Curie in Paris, France, the second meeting of the UM Cure 2020 Scientific Advisory Board (SAB) gave UMCure 2020 SAB members and partners the chance to consider the consortium's successes obtained during its first two years, as well as look forward to the work ahead.

"From Gene to Genome: A story of scientific and self-discovery" - José Baselga delivers the 2017 ESMO Lifetime Achievement Award Lecture

José Baselga received the ESMO Lifetime Achievement Award, celebrating a four-decade career of outstanding relevance in clinical oncology, at the ESMO 2017 conference in Madrid, in his native Spain.

Royal Dutch visit to the Champalimaud Centre for the Unknown

Their Royal Highnesses Queen Maxima and King Willem-Alexander of the Netherlands visited the Champalimaud Centre for the Unknown on 11th October 2017, where they were presented to the UMCure 2020 project.

MPNE Rare 2017, held in Leiden, Netherlands, with ocular, pediatric and other rare melanoma patients, researchers and clinicians

MPNE Rare 2017 was held this past weekend in Leiden University Medical Center, Netherlands.

Groundbreaking study on Uveal Melanoma published in Cancer Cell

An international team, which includes several UMCure 2020 participants, has just identified four distinct UM subtypes with clinical relevance.

First UM Cure 2020 General Assembly and Patients Meeting

Having taken place at Jagiellonian University, in Krakow, Poland, June 15-17 2017, this was a unique gathering that emphasized the importance of consortia as driving forces for the development of new therapies for rare diseases.

Professor Martine Jager elected President of ISOO

"Enthusiasm gets things done."


Dr. Richard Marais presents the UM Cure 2020 project.

24 - 27th March 2017 at Institut Curie, Paris

Postdoctoral Position Open - Molecular Oncology

A three-year postdoctoral position funded by the EU Horizon 2020 Programme is available in the laboratory of Prof. Richard Marais to identify and validate novel therapeutic approaches for the treatment of metastatic uveal melanoma (UM).

2016 World Sight Day

UM Cure 2020 joins in the celebration.

Professor Sarah Coupland elected Vice-president of ARVO

Professor Sarah Coupland, head of the Liverpool Ocular Oncology Group, was elected Vice-president of the Association for Research in Vision and Ophthalmogy, one the foremost scientific organizations in opthalmology worldwide. 

UM CURE 2020 Kick-off Meeting

UM CURE 2020 Kick-off meeting

The kick-off meeting of the UM Cure 2020 project took place January 22-23, 2016, in the exceptional environment of the Champalimaud Foundation in Lisbon, Portugal